Latest News
Nvidia's next big opportunity is in space.
Via The Motley Fool · July 7, 2026
Good medical care will always be in high demand, which makes some healthcare stocks strong long-term picks.
Via The Motley Fool · July 7, 2026
Don't expect SpaceX's stock price to skyrocket after being added to the Nasdaq-100.
Via The Motley Fool · July 7, 2026
Multiple catalysts are driving big sell-offs for Rocket Lab.
Via The Motley Fool · July 7, 2026
While headlines focus on SpaceX's massive debt and losses, these four aerospace stocks offer a potentially more reliable way to profit from the industry's growth.
Via The Motley Fool · July 7, 2026
Samsung crushed earnings, but investors wanted more. Now it -- and other semi stocks -- are being punished.
Via The Motley Fool · July 7, 2026
Does a tidal wave of bullish calls and commentary foreshadow good things to come?
Via The Motley Fool · July 7, 2026
Investors can count on these stocks about as much as any to continue their decades-long runs of excellence.
Via The Motley Fool · July 7, 2026
SK Hynix's Nasdaq listing could raise $28 billion. The company trades at a discount to Micron, even as Micron expands HBM4 capacity and retains strong buy ratings from analysts amid AI memory demand.
Via MarketBeat · July 7, 2026
There's more to young biopharma companies than their numbers, but those numbers are still an important part of each investment thesis.
Via The Motley Fool · July 7, 2026
This saver is starting to take a different approach.
Via The Motley Fool · July 7, 2026
Shares of SK Hynix will start trading on the U.S. stock market this week, and its phenomenal growth and valuation make it a no-brainer buy.
Via The Motley Fool · July 7, 2026
Bank stocks have enjoyed a nice run overall, and valuations are now fairly elevated.
Via The Motley Fool · July 7, 2026
Starlink has been a gem for SpaceX, but it could face an influx of competition in the near future.
Via The Motley Fool · July 7, 2026
Recent reports suggest Meta may rent out excess AI compute. The easy read is that Meta overbuilt and the AI capex cycle is already moving from shortage to surplus. That may be too simple.
Via The Motley Fool · July 7, 2026
ISCB offers ultra-low costs and 1,500+ holdings for diversification, while BBSC concentrates on fewer names with higher recent returns.
Via The Motley Fool · July 7, 2026
Here's why inclusion in the Nasdaq-100 isn't giving SpaceX stock a pop today.
Via The Motley Fool · July 7, 2026
A KOSPI-driven margin cascade triggered trading halts and dragged down U.S. chip stocks like NVIDIA, Broadcom, TSMC and ASML, despite unchanged semiconductor fundamentals.
Via MarketBeat · July 7, 2026
The company has a deep commitment to dividends.
Via The Motley Fool · July 7, 2026
The security and integrity of data are paramount in the digital age, making robust backup and recovery strategies essential components of Tokyo dedicated s
Via Talk Markets · July 7, 2026
The global Cold Plasma Market was valued at USD 167.8 million in 2025 and is projected to grow from USD 191.1 million in 2026 to USD 495.9 million by 2033,
Via Talk Markets · July 7, 2026
An insider disposed of holdings in this business focused on solutions that power global wireless technology standards.
Via The Motley Fool · July 7, 2026
Silver delivered 65.5% returns in one year but with triple gold's drawdown risk. Which bullion fund suits your portfolio?
Via The Motley Fool · July 7, 2026
This key factor didn't exist when Buffett first gave the advice, but does that change its appeal?
Via The Motley Fool · July 7, 2026
The global Cell Analysis Market was valued at USD 34.3 billion in 2025 and is projected to grow from USD 37.3 billion in 2026 to USD 81.0 billion by 2033,
Via Talk Markets · July 7, 2026